We have located links that may give you full text access.
Maternal/Perinatal Outcome in Women with Sickle Cell Disease: A Comparison of Two Time Periods.
Southern Medical Journal 2018 December
OBJECTIVE: To compare pregnancy outcomes in women with sickle cell disease from recent deliveries with a similar group delivered earlier.
METHODS: During a 12-year period (2005-2016), data from pregnant women with hemoglobin SS or SC were collected from three university medical centers and compared with earlier studies (1979-2003) involving similar patients. The primary endpoints were maternal complications during pregnancy and newborn outcomes.
RESULTS: There were 278 patients in the control group (1979-2003) compared with 150 patients in the study group (2005-2016). Women in the study group were older ( P < 0.0001) and of less parity ( P =0.0001), and complications of preterm delivery, preeclampsia, and having a transfusion were similar between the two groups ( P = 0.45, 0.95, and 0.49, respectively). Pain crises were more common in the study group ( P = 0.02) as was cesarean section ( P < 0.0001), but there was a reduction in pulmonary complications ( P = 0.0002). Maternal mortality was uncommon (control group [N=4] vs study group [N=3], P = 0.40). Newborn statistics revealed a similar gestational age at delivery (37 weeks), and the incidence of intrauterine growth restriction, as well as 5-minute Apgar score <7 did not differ by group ( P = 0. 91, 0.85, and 0.16, respectively). Infants in the study group were heavier on average by approximately 220 g ( P = 0.02), whereas the neonatal death rate was low (control group [N=1], study group [N=2] P = 0.60).
CONCLUSIONS: Recent pregnancy outcome statistics in women with sickle cell disease have not changed through the years. Innovative strategies to improve maternal and newborn outcomes among such patients are needed.
METHODS: During a 12-year period (2005-2016), data from pregnant women with hemoglobin SS or SC were collected from three university medical centers and compared with earlier studies (1979-2003) involving similar patients. The primary endpoints were maternal complications during pregnancy and newborn outcomes.
RESULTS: There were 278 patients in the control group (1979-2003) compared with 150 patients in the study group (2005-2016). Women in the study group were older ( P < 0.0001) and of less parity ( P =0.0001), and complications of preterm delivery, preeclampsia, and having a transfusion were similar between the two groups ( P = 0.45, 0.95, and 0.49, respectively). Pain crises were more common in the study group ( P = 0.02) as was cesarean section ( P < 0.0001), but there was a reduction in pulmonary complications ( P = 0.0002). Maternal mortality was uncommon (control group [N=4] vs study group [N=3], P = 0.40). Newborn statistics revealed a similar gestational age at delivery (37 weeks), and the incidence of intrauterine growth restriction, as well as 5-minute Apgar score <7 did not differ by group ( P = 0. 91, 0.85, and 0.16, respectively). Infants in the study group were heavier on average by approximately 220 g ( P = 0.02), whereas the neonatal death rate was low (control group [N=1], study group [N=2] P = 0.60).
CONCLUSIONS: Recent pregnancy outcome statistics in women with sickle cell disease have not changed through the years. Innovative strategies to improve maternal and newborn outcomes among such patients are needed.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app